Annexon Inc. (ANNX)
NASDAQ: ANNX
· Real-Time Price · USD
2.37
-0.23 (-8.85%)
At close: Aug 14, 2025, 3:59 PM
2.35
-0.81%
After-hours: Aug 14, 2025, 07:26 PM EDT
-8.85% (1D)
| Bid | 2.35 |
| Market Cap | 260.02M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -167.38M |
| EPS (ttm) | -1.17 |
| PE Ratio (ttm) | -2.03 |
| Forward PE | -1.62 |
| Analyst | Buy |
| Ask | 2.5 |
| Volume | 1,172,475 |
| Avg. Volume (20D) | 1,475,229 |
| Open | 2.55 |
| Previous Close | 2.60 |
| Day's Range | 2.34 - 2.60 |
| 52-Week Range | 1.28 - 7.85 |
| Beta | 1.30 |
About ANNX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ANNX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ANNX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
-5.52%
Annexon shares are trading higher after the compan...
Unlock content with
Pro Subscription
8 months ago
+13.96%
Annexon shares are trading higher after the company announced topline results from a study supporting Anx005 as a potential treatment for Guillain-barré syndrome.
